Kidney Week

Basic/Clinical Science Session

Incretin-Based Therapies in Nephrology

November 08, 2025 | 02:00 PM - 04:00 PM

Location: Room 332A, Convention Center

Session Description

GLP-1 receptor agonists have evolved from being used strictly for glycemic lowering and weight loss in patients with type 2 diabetes, to a class of drugs with significant kidney and cardiovascular benefits for patients with and without diabetes. This session provides an in-depth primer for nephrology professionals about the use of GLP-1 receptor agonists in people with kidney diseases and other complications and focuses on strategies to mitigate adverse effects.

Learning Objective(s)

• Describe the current incretin landscape across organ systems, from single to triple-G therapies
• Summarize updates from the FLOW trial
• Discuss incretin biology and nondiabetic kidney diseases
• Explain where FLOW fits into nephrology practice

Learning Pathway(s)

• Diabetic Kidney Disease
• Kidney Biology and Physiology

Moderators

• Ricardo Correa-Rotter, MD
• Kaitlin J. Mayne, MBChB, PhD

Presentations

• GLP-1 Receptor Agonist Landscape: From Single to Triple-G Therapies and Beyond
  02:00 PM - 02:30 PM
  
  • Jennifer B. Green, MD

GLP-1 Receptor Agonist Landscape: From Single to Triple-G Therapies and Beyond

November 08, 2025 | 02:00 PM - 02:30 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Incretin Biology and Nondiabetic Kidney Diseases
  02:30 PM - 03:00 PM
  
  • Ayodele Odutayo, MD, MS, MSc, PhD

Incretin Biology and Nondiabetic Kidney Diseases

November 08, 2025 | 02:30 PM - 03:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• Update on the GLP-1 Receptor Agonist End Point Trials: Which Questions Remain Unanswered?
  03:00 PM - 03:30 PM
  
  • Hiddo Jan L. Heerspink, PhD

Update on the GLP-1 Receptor Agonist End Point Trials: Which Questions Remain Unanswered?

November 08, 2025 | 03:00 PM - 03:30 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.

• GLP-1 Receptor Agonist-Based Therapies in Nephrology Practice and Adverse Effect Management
  03:30 PM - 04:00 PM
  
  • Daniël H. van Raalte, MD, PhD

GLP-1 Receptor Agonist-Based Therapies in Nephrology Practice and Adverse Effect Management

November 08, 2025 | 03:30 PM - 04:00 PM

Click an icon below to load this item into your calendar. Please note that times are exported as Coordinated Universal Time (UTC). Time zone help.